| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/DMRR.531 |
| P698 | PubMed publication ID | 15624122 |
| P2093 | author name string | F Charles Brunicardi | |
| Michael A Norman | |||
| Xaio-Ping Wang | |||
| P2860 | cites work | In vitro characterization of somatostatin receptors in the human thymus and effects of somatostatin and octreotide on cultured thymic epithelial cells | Q22008658 |
| C-terminal region of human somatostatin receptor 5 is required for induction of Rb and G1 cell cycle arrest | Q22008681 | ||
| Primary structure of the gene encoding rat preprosomatostatin | Q24300788 | ||
| Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney | Q24337883 | ||
| Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers | Q28138304 | ||
| Somatostatin and its receptor family | Q28141222 | ||
| Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen | Q28141785 | ||
| Quantitative and functional expression of somatostatin receptor subtypes in human thymocytes | Q28206900 | ||
| Genetics of type 1 diabetes mellitus | Q28215982 | ||
| A genome-wide search for human type 1 diabetes susceptibility genes | Q28247197 | ||
| Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family | Q28285445 | ||
| Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis | Q28294253 | ||
| Classification and nomenclature of somatostatin receptors | Q28303973 | ||
| Expression of the five somatostatin receptor (SSTR1-5) subtypes in rat pituitary somatotrophes: quantitative analysis by double-layer immunofluorescence confocal microscopy | Q28571964 | ||
| Chemokines--chemotactic cytokines that mediate inflammation | Q29616433 | ||
| Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis | Q30080034 | ||
| IDDM12 (CTLA4) on 2q33 and IDDM13 on 2q34 in genetic susceptibility to type 1 diabetes (insulin-dependent). | Q30585261 | ||
| Somatostatin stimulates Ca2+-activated K+ channels through protein dephosphorylation | Q48707748 | ||
| Coupling of rat somatostatin receptor subtypes to a G-protein gated inwardly rectifying potassium channel (GIRK1). | Q48948032 | ||
| Immunological abnormalities in islets at diagnosis paralleled further deterioration of glycaemic control in patients with recent-onset Type I (insulin-dependent) diabetes mellitus. | Q51563425 | ||
| Suppression and acceleration of autoimmune diabetes by neutralization of endogenous interleukin-12 in NOD mice. | Q52022615 | ||
| Differential expression of CC chemokines and the CCR5 receptor in the pancreas is associated with progression to type I diabetes. | Q54045893 | ||
| Introduction of homologous DNA sequences into mammalian cells induces mutations in the cognate gene. | Q54419614 | ||
| The role of Fas ligand in beta cell destruction in autoimmune diabetes of NOD mice. | Q55035859 | ||
| The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry | Q55670898 | ||
| A recently described polymorphism in the CD28 gene on chromosome 2q33 is not associated with susceptibility to type 1 diabetes | Q56904317 | ||
| CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes | Q56908828 | ||
| Somatostatin receptors | Q57042835 | ||
| A key role for ICAM-1 in generating effector cells mediating inflammatory responses | Q57227924 | ||
| TRANSGENIC MICE IN THE ANALYSIS OF METABOLIC REGULATION | Q62067333 | ||
| Prevalence of adult-onset IDDM in the U.S. population | Q64112664 | ||
| beta----alpha----delta pancreatic islet cellular perfusion in dogs. | Q64965675 | ||
| The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus. | Q64993164 | ||
| The vascular order of islet cellular perfusion in the human pancreas | Q67512788 | ||
| Perfusion with anti-insulin gamma globulin indicates a B to A to D cellular perfusion sequence in the pancreas of the rhesus monkey, Macaca mulatta | Q67533818 | ||
| Immunohistochemical and histometrical studies of the human thymus with special emphasis on age-related changes in medullary epithelial and dendritic cells | Q68086991 | ||
| Intra-islet regulation | Q69047658 | ||
| The anterograde and retrograde infusion of glucagon antibodies suggests that A cells are vascularly perfused before D cells within the rat islet | Q69372132 | ||
| Distribution of somatostatin receptors on murine spleen and Peyer's patch T and B lymphocytes | Q69919531 | ||
| Dynamic in vivo observation of rat islet microcirculation | Q70528827 | ||
| Somatostatin and macrophage function: modulation of hydrogen peroxide, nitric oxide and tumor necrosis factor release | Q70923132 | ||
| Agonist-dependent regulation of cloned human somatostatin receptor types 1-5 (hSSTR1-5): subtype selective internalization or upregulation | Q71395008 | ||
| The role of CD8+ T cells in the initiation of insulin-dependent diabetes mellitus | Q71420898 | ||
| Differential Expression of Five Somatostatin Receptor Subtypes, SSTR1-5, in the CNS and Peripheral Tissue | Q72114597 | ||
| Molecular cloning and functional expression of a brain-specific somatostatin receptor | Q31164490 | ||
| Cloning of the mouse SSTR5 gene | Q32042474 | ||
| Somatostatin receptors in the haematopoietic system | Q33181416 | ||
| Induction of islet transplantation tolerance using donor specific transfusion and anti-CD154 monoclonal antibody | Q33542704 | ||
| Environmental factors in the pathogenesis of type 1 diabetes mellitus. | Q33752334 | ||
| The role of CD4 and CD8 T cells in the development of autoimmune diabetes | Q33767929 | ||
| The role of CD4 vs. CD8 T cells in IDDM. | Q33767934 | ||
| Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity | Q33897208 | ||
| Suppressor of cytokine signaling 3 (SOCS-3) protects beta -cells against interleukin-1beta - and interferon-gamma -mediated toxicity | Q33947102 | ||
| The somatostatin immunoregulatory circuit present at sites of chronic inflammation | Q34078378 | ||
| Somatostatin receptor subtypes in human immune cells | Q34078382 | ||
| Physiological and pathophysiological role of somatostatin receptors in the human thymus | Q34078386 | ||
| Somatostatin is a selective chemoattractant for primitive (CD34(+)) hematopoietic progenitor cells | Q34112278 | ||
| Peptides as regulators of the immune system: emphasis on somatostatin | Q34126245 | ||
| Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation. | Q34178157 | ||
| Type I diabetes mellitus. A chronic autoimmune disease | Q34181699 | ||
| Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone | Q34216319 | ||
| Human islet transplantation: update. | Q34245824 | ||
| Type 1 diabetes: new perspectives on disease pathogenesis and treatment | Q34321603 | ||
| Multiple gene transcripts of the somatostatin receptor SSTR2: tissue selective distribution and cAMP regulation. | Q34355810 | ||
| Diabetes mellitus and genetically programmed defects in beta-cell function | Q34462316 | ||
| Neuroendocrine aspects of immunolymphoproliferative diseases | Q34474185 | ||
| In-vitro differentiation of pancreatic beta-cells | Q34484370 | ||
| A choice of death--the signal-transduction of immune-mediated beta-cell apoptosis | Q34495385 | ||
| Chemokine receptors: multifaceted therapeutic targets | Q34575325 | ||
| Immunoreactive somatostatin is present in discrete cells of the endocrine pancreas | Q35075503 | ||
| Selective binding of somatostatin-14 and somatostatin-28 to islet cells revealed by quantitative electron microscopic autoradiography | Q35582075 | ||
| The role of MHC class II molecules in susceptibility to type I diabetes: identification of peptide epitopes and characterization of the T cell repertoire | Q35602289 | ||
| CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. | Q36366075 | ||
| Presentation of antigen by endothelial cells and chemoattraction are required for homing of insulin-specific CD8+ T cells. | Q36370525 | ||
| Pancreatic lymph nodes are required for priming of beta cell reactive T cells in NOD mice | Q36370868 | ||
| The role of lymphocyte subsets in accelerated diabetes in nonobese diabetic-rat insulin promoter-B7-1 (NOD-RIP-B7-1) mice | Q36401103 | ||
| Neuropeptides, by direct interaction with T cells, induce cytokine secretion and break the commitment to a distinct T helper phenotype | Q36526442 | ||
| Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors | Q37374477 | ||
| Islet somatostatin--microvascular, paracrine, and pulsatile regulation | Q37599144 | ||
| CD154-dependent priming of diabetogenic CD4(+) T cells dissociated from activation of antigen-presenting cells | Q38288576 | ||
| Late potentials: are they related to cardiovascular complications in children with type 1 diabetes? | Q39608627 | ||
| The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom | Q39736694 | ||
| Fatal attraction: chemokines and type 1 diabetes | Q39740128 | ||
| The order of islet microvascular cellular perfusion is B----A----D in the perfused rat pancreas | Q40377665 | ||
| The adhesion cascade and anti-adhesion therapy: an overview | Q40419219 | ||
| The family of G‐protein‐coupled receptors | Q40439041 | ||
| The somatostatin receptor family. | Q40482710 | ||
| Targeted gene replacement. | Q40728488 | ||
| Heterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization, and desensitization | Q40744546 | ||
| Optimized autoantibody-based risk assessment in family members. Implications for future intervention trials | Q40791302 | ||
| A pancreatic beta -cell-specific enhancer in the human PDX-1 gene is regulated by hepatocyte nuclear factor 3beta (HNF-3beta ), HNF-1alpha, and SPs transcription factors | Q40817135 | ||
| Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). | Q40934999 | ||
| Early infant diets and insulin-dependent diabetes | Q41012417 | ||
| Cellular interactions in thymocyte development. | Q41039662 | ||
| Binding properties of somatostatin receptor subtypes | Q41081376 | ||
| Endocrine Pancreas: Three-Dimensional Reconstruction Shows Two Types of Islets of Langerhans | Q41138694 | ||
| Sexual dimorphism and testosterone-dependent regulation of somatostatin gene expression in the periventricular nucleus of the rat brain | Q41276473 | ||
| Aspartic acid residue 124 in the third transmembrane domain of the somatostatin receptor subtype 3 is essential for somatostatin-14 binding | Q41278828 | ||
| The beta cell transcription factors and development of the pancreas | Q41496269 | ||
| Regulation of Islet Somatostatin Secretion and Gene Expression: Selective Effects of Adenosine 3′,5′- Monophosphate and Phorbol Esters in Normal Islets of Langerhans and in a Somatostatin-Producing Rat Islet Clonal Cell Line 1027 B2* | Q41690348 | ||
| Viruses and other perinatal exposures as initiating events for beta-cell destruction | Q41695561 | ||
| Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes | Q41789085 | ||
| Preferential location of somatostatin receptors in germinal centers of human gut lymphoid tissue | Q41913209 | ||
| Prolonged somatostatin pretreatment desensitizes somatostatin's inhibition of receptor-mediated release of adrenocorticotropin hormone and sensitizes adenylate cyclase | Q42446849 | ||
| Somatostatin Inhibits B-Cell Secretion via a Subtype-2 Somatostatin Receptor in the Isolated Perfused Human Pancreas | Q42481202 | ||
| Somatostatin receptor subtype 1 modulates basal inhibition of growth hormone release in somatotrophs | Q42481826 | ||
| Use of the Fab fragment for immunoneutralization of somatostatin in the isolated perfused human pancreas | Q42491019 | ||
| IPF1/PDX1 deficiency and beta-cell dysfunction in Psammomys obesus, an animal With type 2 diabetes | Q42507820 | ||
| Immunoneutralization of somatostatin, insulin, and glucagon causes alterations in islet cell secretion in the isolated perfused human pancreas | Q42511056 | ||
| Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1 beta-exposed human and rat islet cells | Q43585447 | ||
| Artificial endocrine pancreas | Q43731603 | ||
| Dominant role of intercellular adhesion molecule-1 in the pathogenesis of autoimmune diabetes in non-obese diabetic mice | Q43759565 | ||
| Congenic mapping of the diabetogenic locus Idd4 to a 5.2-cM region of chromosome 11 in NOD mice: identification of two potential candidate subloci | Q43786589 | ||
| Sulfonylurea receptor knockout causes glucose intolerance in mice that is not alleviated by concomitant somatostatin subtype receptor 5 knockout. | Q44009398 | ||
| Comparison of serum concentrations of soluble adhesion molecules in diabetic microangiopathy and macroangiopathy | Q44163405 | ||
| Somatostatin receptor subtype 5 regulates insulin secretion and glucose homeostasis | Q44269095 | ||
| Pancreatic somatostatin inhibits insulin secretion via SSTR-5 in the isolated perfused mouse pancreas model | Q44376890 | ||
| Insulitis in type 1 (insulin-dependent) diabetes mellitus in man--macrophages, lymphocytes, and interferon-gamma containing cells | Q44937498 | ||
| How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model | Q45783598 | ||
| An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus | Q47785242 | ||
| High basal gastric acid secretion in somatostatin receptor subtype 2 knockout mice | Q48019605 | ||
| Cloning and expression of a novel mouse somatostatin receptor (SSTR2B). | Q48152351 | ||
| Somatostatin is expressed in the murine thymus and enhances thymocyte development | Q48550414 | ||
| Somatostatin receptor subtype 2 knockout mice are refractory to growth hormone-negative feedback on arcuate neurons | Q48608364 | ||
| Identification of Human Mononuclear Leukocytes Bearing Receptors for Somatostatin and Glucagon | Q72456636 | ||
| Reversal of Increased Gastric Somatostatin in Streptozotocin-diabetic Rats by Whole Pancreas Transplantation | Q72486921 | ||
| Antisomatostatin Gamma Globulin Augments Secretion of Both Insulin and Glucagon In Vitro: Evidence for a Physiologic Role for Endogenous Somatostatin in the Regulation of Pancreatic A- and B-Cell Function | Q72622348 | ||
| Potent inhibitory effects of a type four receptor-selective somatostatin analog on rat insulin release | Q72661363 | ||
| Regulatory role of intraislet somatostatin on insulin secretion in the isolated perfused human pancreas | Q72678492 | ||
| Specific inhibition of rat pancreatic insulin or glucagon release by receptor-selective somatostatin analogs | Q72903541 | ||
| Age-related decrease of somatostatin receptor number in the normal human thymus | Q72992111 | ||
| Fas and Fas ligand expression in inflamed islets in pancreas sections of patients with recent-onset Type I diabetes mellitus | Q73153922 | ||
| Effects of cholinergic blockade by pirenzepine on insulin and glucose response to oral and intravenous glucose and to arginine load in obesity | Q73165677 | ||
| Circulating antibodies against an exocrine pancreatic enzyme in type 1 diabetes | Q73224777 | ||
| A mechanism for IL-10-mediated diabetes in the nonobese diabetic (NOD) mouse: ICAM-1 deficiency blocks accelerated diabetes | Q73306925 | ||
| Somatostatin inhibits insulin and glucagon secretion via two receptors subtypes: an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice | Q73310120 | ||
| Serological markers of recurrent beta cell destruction in diabetic patients undergoing pancreatic transplantation | Q73398704 | ||
| Population-based genetic screening for the estimation of Type 1 diabetes mellitus risk in Finland: selective genotyping of markers in the HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci | Q73403570 | ||
| Development of low-dose streptozotocin-induced diabetes in ICAM-1-deficient mice | Q73433829 | ||
| Somatostatin receptor subtypes in human thymoma and inhibition of cell proliferation by octreotide in vitro | Q73687582 | ||
| Intraislet regulation of pancreatic polypeptide secretion in the isolated perfused rat pancreas | Q73854070 | ||
| Pancreatic biopsy as a procedure for detecting in situ autoimmune phenomena in type 1 diabetes: close correlation between serological markers and histological evidence of cellular autoimmunity | Q73932422 | ||
| Update on islet-cell transplantation for type 1 diabetes | Q74387510 | ||
| Pancreatic hormone expression in the murine thymus: localization in dendritic cells and macrophages | Q74493415 | ||
| Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study | Q74607777 | ||
| The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7 | Q74650540 | ||
| Dissecting the genetics of type 1 diabetes: relevance for familial clustering and differences in incidence | Q74812215 | ||
| A comparative immunohistochemical study of pancreatic islets in laboratory animals (rats, dogs, minipigs, nonhuman primates) | Q74816782 | ||
| Insulin secretion is inhibited by subtype five somatostatin receptor in the mouse | Q77098085 | ||
| Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop | Q77628562 | ||
| Local expression of TNFalpha in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens | Q77658430 | ||
| Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals | Q77704341 | ||
| sst2 somatostatin receptor mediates cell cycle arrest and induction of p27(Kip1). Evidence for the role of SHP-1 | Q77754899 | ||
| Autoantibodies to GAD, IA-2 and insulin in ICA-positive first-degree relatives of children with type 1 diabetes: a comparison between parents and siblings | Q77841503 | ||
| Repression of NF-kappaB impairs HeLa cell proliferation by functional interference with cell cycle checkpoint regulators | Q77845928 | ||
| Stimulatory transducing systems in pancreatic islet cells | Q77934841 | ||
| Insulin expression levels in the thymus modulate insulin-specific autoreactive T-cell tolerance: the mechanism by which the IDDM2 locus may predispose to diabetes | Q78014697 | ||
| sst5 somatostatin receptor mRNA induction by mitogenic activation of human T-lymphocytes | Q78125284 | ||
| Growth inhibitory effects of somatostatin on human leukemia cell lines mediated by somatostatin receptor subtype 1 | Q78125289 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 15-30 | |
| P577 | publication date | 2005-01-01 | |
| P1433 | published in | Diabetes - Metabolism: Research and Reviews | Q15750056 |
| P1476 | title | Somatostatin receptors and autoimmune-mediated diabetes | |
| P478 | volume | 21 |
Search more.